Calamos Advisors
USNA icon

Calamos Advisors’s Usana Health Sciences USNA Stock Holding History

Calamos Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,780
Closed -$563K – 719
2018
Q4 		$563K Buy
+4,780
New +$553K ﹤0.01% 574

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Calamos Advisors's USNA Position: Q1 2019 in Review

Calamos Advisors sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 4,780 shares — an estimated $563K sold.

Calamos Advisors first reported a position in USNA in Q4 2018 and held it in 1 quarter. The position peaked at $563K in Q4 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • Calamos Advisors reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
  • Calamos Advisors sold 4,780 Usana Health Sciences shares in Q1 2019, an estimated $563K.
  • Calamos Advisors first reported a position in Usana Health Sciences in Q4 2018 and held it in 1 quarter.
  • Calamos Advisors's Usana Health Sciences position peaked at $563K in Q4 2018.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on Calamos Advisors's 13F filing for Q1 2019, filed 12 Apr 2019.